References
- Roberts D J, Spickett R GW, Moragues J, et al. Ebastine. A new non-sedative antihistarnine. Tenth International Congress of Pharmacology. Sydney 1987; 1006
- Vincent J, Limuiana R, Meredith P A, et al. The pharmaco-kinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J CIin Pharmacol 1988; 26: 497–501
- Vincent J, Sumner D J, Reid J L. Ebastine: the effect of a new antihistamine on psychomotor performance and auto-nomic responses in healthy subjects. Br J Clin Pharmacol 1988; 26: 503–8
- Barbanoj M J, Torrent J, Azcona O, et al. Psychomotor performance after different single oral doses of a new non-sedating H1 antihistamine in healthy subjects. XIII International Congress of Allergology and Clinical Immunology, Montreaux, 1988. N Engl Reg Allergy Proc 1988; 9: 435
- Picado C, Cadahía A, Cistero A, et al. Ebatine in perennial allergic rhinitis. Ann Allergy 1991, in press
- Molina M, Cadahia A, Cano L, et al. Efficacy and tolerability of ebastine at 2 dose levels in the treatment of seasonal allergic rhinitis. Drug Investigation 1989; 1: 40–6
- Ankier S I, Warrington S J. A double-blind placebo-controlled study of the efficacy and tolerability of cbastine against hayfever in general practice patients. J Int Med 1989; 226: 453–8
- Matthews K P. The urticarias. Current concepts in patho-genesis and treatment. Drugs 1985; 30: 552–60
- Krause L, Shuster S. Mechanism of action of antipruritic drugs. Br Med J 1983; 287: 1199–200
- Sorkin E M, Heel R C. Terfenadine. A review of its pharma-codynamic properties and therapeutic efficacy. Drug 1985; 29: 35–56
- Richards D M, Brodgen R N, Heel R G, et al. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1984; 28: 38–61
- Luria X, Bakke O, Perez J P. Ebastine: a non-sediative antihistamine H1 with side effect profile similar to that of placebo. IV World Conference on Clinical Pharmacology and Therapeutics. Mannheim 1989; 04.31